Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117236) titled 'TPMT/NUDT15 Preemptive Genotyping to Guide Precision 6-Mercaptopurine Dosing in Chinese Pediatric Patients with Acute Lymphoblastic Leukemia' on Jan. 21.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Fujian Children's Hospital

Condition: acute lymphoblastic leukemia

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-02-01

Target Sample Size: preemptive genetic testing group:200;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=303958

Disclaimer: Curated by HT Syndication....